RecruitingPhase 4NCT06946914

Misoprostol Before Caesarean Section

Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns

Sponsor

Kafrelsheikh University

Enrollment

160 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Caesarean Section Misoprostol Respiratory Distress Syndrome (RDS) of Neonate

Summary

The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.

Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Misoprostol for people with caesarean section, misoprostol, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 20 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMisoprostol

administration of 100mg of misoprostol to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.